宇宙ベースのバイオ医薬品の世界市場レポート 2025年

宇宙ベースのバイオ医薬品市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR11.7％で74億6,000万米ドルに成長します。予測期間の成長は、商業宇宙産業の拡大、宇宙観光の台頭、世界人口の高齢化、個別化医療への需要の高まり、宇宙研究への投資の増加によって牽引されると予想されます。予測期間の主な動向には、遠隔生物製剤製造、AI主導の実験設計、遠隔医療と宇宙研究の統合、分析装置の小型化、自動宇宙実験プラットフォームの開発などが含まれます。

先進的な治療薬に対する需要の増加は、宇宙ベースのバイオ医薬品市場の成長を促進すると予想されます。遺伝子治療、細胞治療、生物製剤を含むこれらの次世代治療は、分子または細胞レベルで病気をターゲットにすることを目的としています。需要の高まりは、がん、遺伝性疾患、自己免疫疾患のような複雑で慢性的な疾患の有病率が高まっていることが背景にあり、従来の方法よりも個別化され、ターゲットを絞った効果的な治療が求められています。宇宙ベースのバイオ医薬品は、微小重力というユニークな環境を利用して薬効を向上させ、複雑な生物製剤の生産をスピードアップすることで、この需要に応える一助となります。例えば、2023年12月、英国の先進治療センターは、2021年から2022年の間に先進治療への投資が31％増加したと報告しました。この動向は、先端治療薬に対する需要の高まりが宇宙ベースのバイオ医薬品市場の拡大を促進していることを示しています。

宇宙ベースのバイオ医薬品市場の企業は、最先端技術を統合するために戦略的提携を結ぶことが増えています。これらの提携は、LIFE Pathfinderモジュールに高度なバイオ医薬品と製造施設を提供することに重点を置いており、バイオ医薬品研究と製造の厳しい基準を満たすように設計されています。例えば、2023年8月、米国の商業宇宙企業であるシエラ・スペース社は、レッドワイヤー社と提携し、地球低軌道（LEO）における商業製薬およびバイオテクノロジー研究能力を開発しました。この提携には、シエラスペースのLIFEハビタット・プラットフォームに組み込む高度なバイオテクノロジーと製造技術の提供も含まれます。この技術には、高分子結晶化装置、工業用結晶製造装置、温度勾配炉などが含まれ、これらはすべて微小重力下での医薬品開発とヒトの健康研究をサポートすることを目的としています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界宇宙ベースのバイオ医薬品 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の宇宙ベースのバイオ医薬品市場：成長率分析
• 世界の宇宙ベースのバイオ医薬品市場の実績：規模と成長, 2019-2024
• 世界の宇宙ベースのバイオ医薬品市場の予測：規模と成長, 2024-2029, 2034F
• 世界宇宙ベースのバイオ医薬品総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の宇宙ベースのバイオ医薬品市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ワクチン
• 治療薬
• 診断
• その他の製品タイプ
• 世界の宇宙ベースのバイオ医薬品市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• がん治療
• 感染症
• 遺伝性疾患
• その他の用途
• 世界の宇宙ベースのバイオ医薬品市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 製薬会社
• 調査機関
• ヘルスケア提供者
• その他のエンドユーザー
• 世界の宇宙ベースのバイオ医薬品市場、ワクチンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 感染症ワクチン
• がんワクチン
• RNAベースのワクチン
• 治療ワクチン
• 予防ワクチン
• 世界の宇宙ベースのバイオ医薬品市場、治療薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• モノクローナル抗体
• 遺伝子治療
• 細胞療法
• タンパク質ベースの治療法
• ペプチドベースの治療法
• 世界の宇宙ベースのバイオ医薬品市場、診断のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 分子診断
• 免疫測定
• ポイントオブケア診断
• バイオマーカーの発見
• 体外診断
• 世界の宇宙ベースのバイオ医薬品市場、その他の製品タイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 再生医療
• 生物学的製剤
• 組織工学製品
• 生化学試薬
• 宇宙調査用実験消耗品

第7章 地域別・国別分析

• 世界の宇宙ベースのバイオ医薬品市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の宇宙ベースのバイオ医薬品市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 宇宙ベースのバイオ医薬品市場：競合情勢
• 宇宙ベースのバイオ医薬品市場：企業プロファイル
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • Sierra Space Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Rocket Lab USA Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Redwire Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Axiom Space Inc.
• Varda Space Industries Inc.
• Nanoracks LLC
• ResearchSat Pty Ltd.
• Techshot Inc.
• Space Tango Inc.
• nScrypt Inc.
• SpacePharma SA
• Space Forge Ltd.
• LambdaVision Inc.
• Kibo Biotech Platform
• ISS National Lab
• BioServe Space Technologies
• Space LiinTech
• BioOrbit

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 宇宙ベースのバイオ医薬品市場2029：新たな機会を提供する国
• 宇宙ベースのバイオ医薬品市場2029：新たな機会を提供するセグメント
• 宇宙ベースのバイオ医薬品市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Space-based biopharmaceuticals are drugs and biologics that are developed or produced in the unique conditions of space, especially microgravity. These conditions can improve processes such as protein crystallization and drug stability. The goal is to use space's environment to create more effective treatments and innovative compounds that may not be possible to develop on Earth.

The primary categories of space-based biopharmaceuticals include vaccines, therapeutics, diagnostics, and other related products. Research conducted in space helps create vaccines that are more stable and effective by utilizing microgravity to improve antigen stability, protein crystallization, and immune response modeling. These products are applied in areas such as cancer treatment, infectious diseases, genetic disorders, and various other health conditions. The main users of these products include pharmaceutical companies, research organizations, healthcare providers, and additional stakeholders.

The space-based biopharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides space-based biopharmaceuticals market statistics, including the space-based biopharmaceuticals industry global market size, regional shares, competitors with the space-based biopharmaceuticals market share, detailed space-based biopharmaceuticals market segments, market trends, and opportunities, and any further data you may need to thrive in the space-based biopharmaceuticals industry. This space-based biopharmaceuticals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The space-based biopharmaceuticals market size has grown rapidly in recent years. It will grow from $4.29 billion in 2024 to $4.80 billion in 2025 at a compound annual growth rate (CAGR) of 11.9%. The growth observed during the historic period can be credited to the rising demand for high-quality biopharmaceuticals, the emergence of private companies in the space sector, increased financial investment in space missions, the development and functionality of space stations, and the expansion of space-based manufacturing.

The space-based biopharmaceuticals market size is expected to see rapid growth in the next few years. It will grow to $7.46 billion in 2029 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period is expected to be driven by the expansion of the commercial space industry, the rise of space tourism, the aging global population, the growing demand for personalized medicine, and increased investment in space research. Key trends for the forecast period include remote biologics manufacturing, AI-driven experiment design, integration of telemedicine with space research, miniaturization of analytical devices, and the development of automated space lab platforms.

The increasing demand for advanced therapeutics is expected to drive the growth of the space-based biopharmaceuticals market. These next-generation treatments, including gene therapy, cell therapy, and biologics, aim to target diseases at the molecular or cellular level. The rising demand is fueled by the growing prevalence of complex and chronic conditions such as cancer, genetic disorders, and autoimmune diseases, which require more personalized, targeted, and effective therapies than traditional methods offer. Space-based biopharmaceuticals help meet this demand by using the unique environment of microgravity to improve drug efficacy and speed up the production of complex biologics. For example, in December 2023, the Advanced Therapy Treatment Centre in the UK reported a 31% increase in investment in advanced therapies between 2021 and 2022. This trend demonstrates how the growing demand for advanced therapeutics is driving the expansion of the space-based biopharmaceuticals market.

Companies in the space-based biopharmaceuticals market are increasingly forming strategic alliances to integrate cutting-edge technology. These collaborations focus on providing advanced biopharma and manufacturing facilities for the LIFE Pathfinder module, which are designed to meet the rigorous standards of biopharmaceutical research and production. For example, in August 2023, Sierra Space, a US-based commercial space company, partnered with Redwire Corporation to develop commercial pharmaceutical and biotech research capabilities in low-Earth orbit (LEO). This partnership also involves providing advanced biotechnology and manufacturing technologies to be incorporated into Sierra Space's LIFE habitat platform. The technologies include equipment for large molecule crystallization, industrial crystal manufacturing, and gradient-temperature furnaces, all aimed at supporting pharmaceutical drug development and human health research in microgravity.

In March 2025, Sierra Space joined forces with Yuri, a Germany-based space biotech company specializing in microgravity research and bioreactor technology. The goal of this partnership is to accelerate medical and biological research in space, facilitating innovative drug discovery and the development of advanced therapeutic solutions for diseases on Earth.

Major players in the space-based biopharmaceuticals market are Merck & Co. Inc., Bristol-Myers Squibb Company, Sierra Space Corporation, Rocket Lab USA Inc., Redwire Corporation, Axiom Space Inc., Varda Space Industries Inc., Nanoracks LLC, ResearchSat Pty Ltd., Techshot Inc., Space Tango Inc., nScrypt Inc., SpacePharma SA, Space Forge Ltd., LambdaVision Inc., Kibo Biotech Platform, ISS National Lab, BioServe Space Technologies, Space LiinTech, BioOrbit.

North America was the largest region in the space-based biopharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in space-based biopharmaceuticals report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the space-based biopharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The space-based biopharmaceuticals market consists of revenues earned by entities by providing services such as microgravity research, in-space manufacturing, ISS utilization, and biocrystal optimization services. The market value includes the value of related goods sold by the service provider or included within the service offering. The space-based biopharmaceuticals market also consists of sales of products including protein crystals for drug development, artificial retinas, stem cell-based therapies, and drug delivery systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Space-Based Biopharmaceuticals Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on space-based biopharmaceuticals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for space-based biopharmaceuticals ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The space-based biopharmaceuticals market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Vaccines; Therapeutics; Diagnostics; Other Product Types
• 2) By Application: Cancer Treatment; Infectious Diseases; Genetic Disorders; Other Applications
• 3) By End-User: Pharmaceutical Companies; Research Institutes; Healthcare Providers; Other End Users
• Subsegment:
• 1) By Vaccines: Infectious Disease Vaccines; Cancer Vaccines; RNA-Based Vaccines; Therapeutic Vaccines; Preventive Vaccines
• 2) By Therapeutics: Monoclonal Antibodies; Gene Therapies; Cell Therapies; Protein-Based Therapies; Peptide-Based Therapies
• 3) By Diagnostics: Molecular Diagnostics; Immunoassays; Point-of-Care Diagnostics; Biomarker Discovery; In Vitro Diagnostics
• 4) By Other Product Types: Regenerative Medicines; Biologics; Tissue Engineering Products; Bio-Chemical Reagents; Laboratory Consumables for Space Research
• Companies Mentioned: Merck & Co. Inc.; Bristol-Myers Squibb Company; Sierra Space Corporation; Rocket Lab USA Inc.; Redwire Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Space-Based Biopharmaceuticals Market Characteristics

3. Space-Based Biopharmaceuticals Market Trends And Strategies

4. Space-Based Biopharmaceuticals Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Space-Based Biopharmaceuticals Growth Analysis And Strategic Analysis Framework

• 5.1. Global Space-Based Biopharmaceuticals PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Space-Based Biopharmaceuticals Market Growth Rate Analysis
• 5.4. Global Space-Based Biopharmaceuticals Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Space-Based Biopharmaceuticals Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Space-Based Biopharmaceuticals Total Addressable Market (TAM)

6. Space-Based Biopharmaceuticals Market Segmentation

• 6.1. Global Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vaccines
• Therapeutics
• Diagnostics
• Other Product Types
• 6.2. Global Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cancer Treatment
• Infectious Diseases
• Genetic Disorders
• Other Applications
• 6.3. Global Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical Companies
• Research Institutes
• Healthcare Providers
• Other End Users
• 6.4. Global Space-Based Biopharmaceuticals Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infectious Disease Vaccines
• Cancer Vaccines
• RNA-Based Vaccines
• Therapeutic Vaccines
• Preventive Vaccines
• 6.5. Global Space-Based Biopharmaceuticals Market, Sub-Segmentation Of Therapeutics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monoclonal Antibodies
• Gene Therapies
• Cell Therapies
• Protein-Based Therapies
• Peptide-Based Therapies
• 6.6. Global Space-Based Biopharmaceuticals Market, Sub-Segmentation Of Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Molecular Diagnostics
• Immunoassays
• Point-of-Care Diagnostics
• Biomarker Discovery
• In Vitro Diagnostics
• 6.7. Global Space-Based Biopharmaceuticals Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Regenerative Medicines
• Biologics
• Tissue Engineering Products
• Bio-Chemical Reagents
• Laboratory Consumables for Space Research

7. Space-Based Biopharmaceuticals Market Regional And Country Analysis

• 7.1. Global Space-Based Biopharmaceuticals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Space-Based Biopharmaceuticals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Space-Based Biopharmaceuticals Market

• 8.1. Asia-Pacific Space-Based Biopharmaceuticals Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Space-Based Biopharmaceuticals Market

• 9.1. China Space-Based Biopharmaceuticals Market Overview
• 9.2. China Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Space-Based Biopharmaceuticals Market

• 10.1. India Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Space-Based Biopharmaceuticals Market

• 11.1. Japan Space-Based Biopharmaceuticals Market Overview
• 11.2. Japan Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Space-Based Biopharmaceuticals Market

• 12.1. Australia Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Space-Based Biopharmaceuticals Market

• 13.1. Indonesia Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Space-Based Biopharmaceuticals Market

• 14.1. South Korea Space-Based Biopharmaceuticals Market Overview
• 14.2. South Korea Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Space-Based Biopharmaceuticals Market

• 15.1. Western Europe Space-Based Biopharmaceuticals Market Overview
• 15.2. Western Europe Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Space-Based Biopharmaceuticals Market

• 16.1. UK Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Space-Based Biopharmaceuticals Market

• 17.1. Germany Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Space-Based Biopharmaceuticals Market

• 18.1. France Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Space-Based Biopharmaceuticals Market

• 19.1. Italy Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Space-Based Biopharmaceuticals Market

• 20.1. Spain Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Space-Based Biopharmaceuticals Market

• 21.1. Eastern Europe Space-Based Biopharmaceuticals Market Overview
• 21.2. Eastern Europe Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Space-Based Biopharmaceuticals Market

• 22.1. Russia Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Space-Based Biopharmaceuticals Market

• 23.1. North America Space-Based Biopharmaceuticals Market Overview
• 23.2. North America Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Space-Based Biopharmaceuticals Market

• 24.1. USA Space-Based Biopharmaceuticals Market Overview
• 24.2. USA Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Space-Based Biopharmaceuticals Market

• 25.1. Canada Space-Based Biopharmaceuticals Market Overview
• 25.2. Canada Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Space-Based Biopharmaceuticals Market

• 26.1. South America Space-Based Biopharmaceuticals Market Overview
• 26.2. South America Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Space-Based Biopharmaceuticals Market

• 27.1. Brazil Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Space-Based Biopharmaceuticals Market

• 28.1. Middle East Space-Based Biopharmaceuticals Market Overview
• 28.2. Middle East Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Space-Based Biopharmaceuticals Market

• 29.1. Africa Space-Based Biopharmaceuticals Market Overview
• 29.2. Africa Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Space-Based Biopharmaceuticals Market Competitive Landscape And Company Profiles

• 30.1. Space-Based Biopharmaceuticals Market Competitive Landscape
• 30.2. Space-Based Biopharmaceuticals Market Company Profiles
  • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sierra Space Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Rocket Lab USA Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Redwire Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Space-Based Biopharmaceuticals Market Other Major And Innovative Companies

• 31.1. Axiom Space Inc.
• 31.2. Varda Space Industries Inc.
• 31.3. Nanoracks LLC
• 31.4. ResearchSat Pty Ltd.
• 31.5. Techshot Inc.
• 31.6. Space Tango Inc.
• 31.7. nScrypt Inc.
• 31.8. SpacePharma SA
• 31.9. Space Forge Ltd.
• 31.10. LambdaVision Inc.
• 31.11. Kibo Biotech Platform
• 31.12. ISS National Lab
• 31.13. BioServe Space Technologies
• 31.14. Space LiinTech
• 31.15. BioOrbit

32. Global Space-Based Biopharmaceuticals Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Space-Based Biopharmaceuticals Market

34. Recent Developments In The Space-Based Biopharmaceuticals Market

35. Space-Based Biopharmaceuticals Market High Potential Countries, Segments and Strategies

• 35.1 Space-Based Biopharmaceuticals Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Space-Based Biopharmaceuticals Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Space-Based Biopharmaceuticals Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer